Skip to main content
Top
Published in: BMC Ophthalmology 1/2018

Open Access 01-12-2018 | Research article

Factors related to survival outcomes following orbital exenteration: a retrospective, comparative, case series

Authors: Orapan Aryasit, Passorn Preechawai, Chakree Hirunpat, Orasa Horatanaruang, Penny Singha

Published in: BMC Ophthalmology | Issue 1/2018

Login to get access

Abstract

Background

Orbital exenteration is a disfiguring procedure that aims to achieve local control. It is commonly a part of the management of malignant orbital tumor which is a life-threatening condition. It is necessary to determine predictive factors associated with overall survival (OS) following orbital exenteration.

Methods

This was a retrospective, comparative, case series of 39 patients with malignant tumors who underwent orbital exenteration. Patient records were reviewed for age, clinical presentation, preoperative visual acuity (VA), tumor size, surgical margin, tumor invasiveness, recurrent disease, and status of distant metastasis. Kaplan-Meier curves were used to assess OS and event-free survival (EFS). The predictive factors related to OS were identified using multivariate analysis.

Results

The mean age was 62.9 years (range, 5.5 to 89.7 years), 68.4% presented with VA < 20/400. The mean size of all tumors was 32 ± 18 mm. Distant metastasis at diagnosis was reported in 11 patients (28.2%). Twenty-two patients died during follow-up. The median OS and EFS were 3.89 years and 3.01 years, respectively. The predictive factors for worse OS on multivariate analysis were preoperative VA < 20/400 (adjusted hazard ratio [aHR] 4.67, P = 0.003), tumor size larger than 20 mm (aHR 3.14, P = 0.022,) and positive distant metastasis at diagnosis (aHR 15.31, P <  0.001).

Conclusions

The prognostic factors for poor survival outcome following orbital exenteration were a preoperative VA < 20/400, tumor size > 20 mm, and distant metastasis at diagnosis mostly due to patient negligence.
Literature
1.
go back to reference Goldberg RA, Kim JW, Shorr N. Orbital exenteration: results of an individualized approach. Ophthal Plast Reconstr Surg. 2003;19:229–36.CrossRefPubMed Goldberg RA, Kim JW, Shorr N. Orbital exenteration: results of an individualized approach. Ophthal Plast Reconstr Surg. 2003;19:229–36.CrossRefPubMed
2.
go back to reference Ben Simon GJ, Schwarcz RM, Douglas R, Fiaschetti D, McCann JD, Goldberg RA. Orbital exenteration: one size does not fit all. Am J Ophthalmol. 2005;139:11–7.CrossRefPubMed Ben Simon GJ, Schwarcz RM, Douglas R, Fiaschetti D, McCann JD, Goldberg RA. Orbital exenteration: one size does not fit all. Am J Ophthalmol. 2005;139:11–7.CrossRefPubMed
3.
go back to reference Wong JC, Thampy R, Cook A. Life expectancy following orbital exenteration. Br J Ophthalmol. 2015;99:1–4.CrossRefPubMed Wong JC, Thampy R, Cook A. Life expectancy following orbital exenteration. Br J Ophthalmol. 2015;99:1–4.CrossRefPubMed
4.
go back to reference Gerring RC, Ott CT, Curry JM, Sargi ZB, Wester ST. Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival. Eye (Lond). 2017;31:379–88.CrossRef Gerring RC, Ott CT, Curry JM, Sargi ZB, Wester ST. Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival. Eye (Lond). 2017;31:379–88.CrossRef
5.
go back to reference Limawararut V, Leibovitch I, Sullivan T, Selva D. Periocular squamous cell carcinoma. Clin Exp Ophthalmol. 2007;35:174–85.CrossRefPubMed Limawararut V, Leibovitch I, Sullivan T, Selva D. Periocular squamous cell carcinoma. Clin Exp Ophthalmol. 2007;35:174–85.CrossRefPubMed
7.
go back to reference Nilforushan N, Askari S, Karimi N. A common pitfall in glaucoma treatment success assessment. J Glaucoma. 2017;26:195–6.CrossRef Nilforushan N, Askari S, Karimi N. A common pitfall in glaucoma treatment success assessment. J Glaucoma. 2017;26:195–6.CrossRef
9.
go back to reference Bartley GB, Garrity JA, Waller RR, Henderson JW, Ilstrup DM. Orbital exenteration at the Mayo Clinic. 1967-1986. Ophthalmology. 1989;96:468–73.CrossRefPubMed Bartley GB, Garrity JA, Waller RR, Henderson JW, Ilstrup DM. Orbital exenteration at the Mayo Clinic. 1967-1986. Ophthalmology. 1989;96:468–73.CrossRefPubMed
10.
go back to reference Levin PS, Dutton JJ. A 20-year series of orbital exenteration. Am J Ophthalmol. 1991;112:496–501.CrossRefPubMed Levin PS, Dutton JJ. A 20-year series of orbital exenteration. Am J Ophthalmol. 1991;112:496–501.CrossRefPubMed
11.
go back to reference Mohr C, Esser J. Orbital exenteration: surgical and reconstructive strategies. Graefes Arch Clin Exp Ophthalmol. 1997;235:288–95.CrossRefPubMed Mohr C, Esser J. Orbital exenteration: surgical and reconstructive strategies. Graefes Arch Clin Exp Ophthalmol. 1997;235:288–95.CrossRefPubMed
12.
go back to reference Rathbun JE, Beard C, Quickert MH. Evaluation of 48 cases of orbital exenteration. Am J Ophthalmol. 1971;72:191–9.CrossRefPubMed Rathbun JE, Beard C, Quickert MH. Evaluation of 48 cases of orbital exenteration. Am J Ophthalmol. 1971;72:191–9.CrossRefPubMed
13.
go back to reference Simons JN, Robinson DW, Masters FW. Malignant tumours of the orbit and periorbital structures treated by exenteration. Plast Reconstr Surg. 1966;37:100–4.CrossRefPubMed Simons JN, Robinson DW, Masters FW. Malignant tumours of the orbit and periorbital structures treated by exenteration. Plast Reconstr Surg. 1966;37:100–4.CrossRefPubMed
14.
go back to reference de Conciliis C, Bonavolonta G. Incidence and treatment of dural exposure and CSF leak during orbital exenteration. Ophthal Plast Reconstr Surg. 1987;3:61–4.CrossRefPubMed de Conciliis C, Bonavolonta G. Incidence and treatment of dural exposure and CSF leak during orbital exenteration. Ophthal Plast Reconstr Surg. 1987;3:61–4.CrossRefPubMed
15.
go back to reference Mouriaux F, Martinot V, Pellerin P, Patenotre P, Rouland JF, Constantinides G. Survival after malignant tumours of the orbit and periorbit treated by exenteration. Acta Ophthalmol. 1999;77:326–30.CrossRef Mouriaux F, Martinot V, Pellerin P, Patenotre P, Rouland JF, Constantinides G. Survival after malignant tumours of the orbit and periorbit treated by exenteration. Acta Ophthalmol. 1999;77:326–30.CrossRef
16.
go back to reference Pushker N, Kashyap S, Balasubramanya R, Bajaj MS, Sen S, Betharia SM, et al. Pattern of orbital exenteration in a tertiary eye care Centre in India. Clin Exp Ophthalmol. 2004;32:51–4.CrossRefPubMed Pushker N, Kashyap S, Balasubramanya R, Bajaj MS, Sen S, Betharia SM, et al. Pattern of orbital exenteration in a tertiary eye care Centre in India. Clin Exp Ophthalmol. 2004;32:51–4.CrossRefPubMed
17.
go back to reference Ali MJ, Pujari A, Dave TV, Kaliki S, Naik MN. Clinicopathological profile of orbital exenteration: 14 years of experience from a tertiary eye care center in South India. Int Ophthalmol. 2016;36:253–8.CrossRefPubMed Ali MJ, Pujari A, Dave TV, Kaliki S, Naik MN. Clinicopathological profile of orbital exenteration: 14 years of experience from a tertiary eye care center in South India. Int Ophthalmol. 2016;36:253–8.CrossRefPubMed
18.
go back to reference Lee GA, Williams G, Hirst LW, Green AC. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology. 1994;101:360–4.CrossRefPubMed Lee GA, Williams G, Hirst LW, Green AC. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology. 1994;101:360–4.CrossRefPubMed
20.
go back to reference Sepulveda R, Pe'er J, Midena E, Seregard S, Dua HS, Singh AD. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmology. 2010;94:532–5.CrossRef Sepulveda R, Pe'er J, Midena E, Seregard S, Dua HS, Singh AD. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmology. 2010;94:532–5.CrossRef
21.
go back to reference Karabekmez FE, Selimoglu MN, Duymaz A, Karamese MS, Keskin M, Savaci N. Management of neglected periorbital squamous cell carcinoma requiring orbital exenteration. J Craniofac Surg. 2014;25:729–34.CrossRefPubMed Karabekmez FE, Selimoglu MN, Duymaz A, Karamese MS, Keskin M, Savaci N. Management of neglected periorbital squamous cell carcinoma requiring orbital exenteration. J Craniofac Surg. 2014;25:729–34.CrossRefPubMed
22.
go back to reference Kersten RC, Tse DT, Anderson RL, Blodi FC. The role of orbital exenteration in choroidal melanoma with extrascleral extension. Ophthalmology. 1985;92:436–43.CrossRefPubMed Kersten RC, Tse DT, Anderson RL, Blodi FC. The role of orbital exenteration in choroidal melanoma with extrascleral extension. Ophthalmology. 1985;92:436–43.CrossRefPubMed
23.
go back to reference Pach JM, Robertson DM, Taney BS, Martin JA, Campbell RJ, O'Brien PC. Prognostic factors in choroidal and ciliary body melanomas with extrascleral extension. Am J Ophthalmol. 1986;101:325–31.CrossRefPubMed Pach JM, Robertson DM, Taney BS, Martin JA, Campbell RJ, O'Brien PC. Prognostic factors in choroidal and ciliary body melanomas with extrascleral extension. Am J Ophthalmol. 1986;101:325–31.CrossRefPubMed
24.
go back to reference Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Ophthalmology. 2005;112:834–40.CrossRefPubMed Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Ophthalmology. 2005;112:834–40.CrossRefPubMed
25.
go back to reference Radhakrishnan V, Kashyap S, Pushker N, Sharma S, Pathy S, Mohanti BK, et al. Outcome, pathologic findings, and compliance in orbital retinoblastoma (international retinoblastoma staging system stage III) treated with neoadjuvant chemotherapy: a prospective study. Ophthalmology. 2012;119:1470–7.CrossRefPubMed Radhakrishnan V, Kashyap S, Pushker N, Sharma S, Pathy S, Mohanti BK, et al. Outcome, pathologic findings, and compliance in orbital retinoblastoma (international retinoblastoma staging system stage III) treated with neoadjuvant chemotherapy: a prospective study. Ophthalmology. 2012;119:1470–7.CrossRefPubMed
26.
go back to reference Shields JA, Shields CL, Freire JE, Brady LW, Komarnicky L. Plaque radiotherapy for selected orbital malignancies: preliminary observations: the 2002 Montgomery lecture, part 2. Ophthal Plast Reconstr Surg. 2003;19:91–5.CrossRefPubMed Shields JA, Shields CL, Freire JE, Brady LW, Komarnicky L. Plaque radiotherapy for selected orbital malignancies: preliminary observations: the 2002 Montgomery lecture, part 2. Ophthal Plast Reconstr Surg. 2003;19:91–5.CrossRefPubMed
27.
go back to reference Tyers AG. Orbital exenteration for invasive skin tumours. Eye (Lond). 2006;20:1165–70.CrossRef Tyers AG. Orbital exenteration for invasive skin tumours. Eye (Lond). 2006;20:1165–70.CrossRef
28.
go back to reference Esmaeli B, Nasser QJ, Cruz H, Fellman M, Warneke CL, Ivan D. American joint committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology. 2012;119:1078–82.CrossRefPubMed Esmaeli B, Nasser QJ, Cruz H, Fellman M, Warneke CL, Ivan D. American joint committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology. 2012;119:1078–82.CrossRefPubMed
29.
go back to reference Nasser QJ, Roth KG, Warneke CL, Yin VT, El Sawy T, Esmaeli B. Impact of AJCC 'T' designation on risk of regional lymph node metastasis in patients with squamous carcinoma of the eyelid. Br J Ophthalmol. 2014;98:498–501.CrossRefPubMed Nasser QJ, Roth KG, Warneke CL, Yin VT, El Sawy T, Esmaeli B. Impact of AJCC 'T' designation on risk of regional lymph node metastasis in patients with squamous carcinoma of the eyelid. Br J Ophthalmol. 2014;98:498–501.CrossRefPubMed
30.
go back to reference Nemet AY, Martin P, Benger R, Kourt G, Sharma V, Ghabrial R, et al. Orbital exenteration: a 15-year study of 38 cases. Ophthal Plast Reconstr Surg. 2007;23:468–72.CrossRefPubMed Nemet AY, Martin P, Benger R, Kourt G, Sharma V, Ghabrial R, et al. Orbital exenteration: a 15-year study of 38 cases. Ophthal Plast Reconstr Surg. 2007;23:468–72.CrossRefPubMed
Metadata
Title
Factors related to survival outcomes following orbital exenteration: a retrospective, comparative, case series
Authors
Orapan Aryasit
Passorn Preechawai
Chakree Hirunpat
Orasa Horatanaruang
Penny Singha
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2018
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-018-0850-y

Other articles of this Issue 1/2018

BMC Ophthalmology 1/2018 Go to the issue